XML 23 R10.htm IDEA: XBRL DOCUMENT
v3.19.2

LOSS PER SHARE AND STOCKHOLDERS’ EQUITY: | 3 Months Ended
--- | ---
Jun. 30, 2019
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY: |
LOSS PER SHARE AND STOCKHOLDERS' EQUITY: | LOSS PER SHARE AND STOCKHOLDERS’ EQUITY: Loss Per Share A reconciliation of the numerator and denominator of basic and diluted loss per share is shown below (in thousands, except per share amounts):
|  | For the three months ended |  |  |  |  |  |
|  | June 30, |  |  |  |  |  |
|  | 2019 |  | 2018 |  |  |  |
Basic loss per share: |  |  |  |  |  |  |  |
Net loss from continuing operations |  | $ | (42,140) |  | $ | (27,818) |  |  |  |
Earnings from discontinued operations, net of tax |  | — |  | 24,803 |  |  |  |
Net loss |  | $ | (42,140) |  | $ | (3,015) |  |  |  |
Basic weighted-average shares outstanding |  | 68,906 |  | 76,935 |  |  |  |
Continuing operations |  | $ | (0.61) |  | $ | (0.36) |  |  |  |
Discontinued operations |  | — |  | 0.32 |  |  |  |
Basic loss per share |  | $ | (0.61) |  | $ | (0.04) |  |  |  |
Diluted loss per share: |  |  |  |  |  |  |  |
Basic weighted-average shares outstanding |  | 68,906 |  | 76,935 |  |  |  |
Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method |  | — |  | — |  |  |  |
Diluted weighted-average shares outstanding |  | 68,906 |  | 76,935 |  |  |  |
Continuing operations |  | $ | (0.61) |  | $ | (0.36) |  |  |  |
Discontinued operations |  | — |  | 0.32 |  |  |  |
Diluted loss per share |  | $ | (0.61) |  | $ | (0.04) |  |  |  |
Due to the net loss from continuing operations during the three months ended June 30, 2019 and 2018, the dilutive effect of options and restricted stock units covering 2.8 million and 2.3 million shares of common stock, respectively was excluded from the diluted loss per share calculation since the impact on the calculation was anti-dilutive. Additional options to purchase shares of common stock and restricted stock units that were outstanding during the periods presented but were not included in the computation of diluted loss per share because the effect was anti-dilutive are shown below (shares in thousands):
|  | For the three months ended |  |  |  |  |  |
|  | June 30, |  |  |  |  |  |
|  | 2019 |  | 2018 |  |  |  |
Number of shares outstanding under options, warrants and restricted stock units plans |  | 431 |  | 119 |  |  |  |
Range of exercise prices for options |  | N/A |  | $ | 32.85 |  |  |  |
Stockholders’ Equity Under the modified common stock repurchase program, the Company may purchase up to $1.0 billion of its common stock through the period ending December 31, 2020. During the three months ended June 30, 2019, the Company repurchased 0.4 million shares of its common stock for $20.1 million under the stock repurchase program. Through June 30, 2019, the Company had repurchased a total of 23.0 million shares of its stock for $469.2 million under the stock repurchase program, leaving remaining capacity of $530.8 million. Accumulated other comprehensive income accumulated balances of $7.3 million and $7.8 million at June 30, 2019 and March 31, 2019, respectively, reflect accumulated foreign currency translation adjustments.

X
- References No definition available. + Details
Name: | ramp_EarningsPerShareAndStockholdersEquityDisclosureAbstract
Namespace Prefix: | ramp_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ramp_EarningsPerShareAndStockholdersEquityDisclosureTextBlock
Namespace Prefix: | ramp_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration